Gut5 Oct 2026
A panel of experts reached consensus on guidelines for clinical trials evaluating systemic therapies in hepatocellular carcinoma (HCC) patients undergoing surgical or locoregional treatment, emphasizing patient selection and outcome measures.
Br J Surg5 Oct 2026
Intraoperative indocyanine green (ICG) fluorescence imaging did not provide a clinically relevant benefit for lymph node dissection in gastric cancer surgery among western patients.
J Am Coll Surg5 Oct 2026
Minimally invasive techniques for primary ventral hernia repair yield better patient-reported outcomes in terms of scar dissatisfaction compared to open repair, though recurrence rates differ by technique.
BMC Surg5 Oct 2026
A novel Y-shaped layered antireflux anastomosis significantly improves outcomes in esophagectomy compared to traditional circular-stapled techniques.
BMC Surg5 Oct 2026
Surgery for stage I-III colon cancer performed within 48 days of diagnosis significantly improves 5-year survival compared to later procedures.
BMC Surg2 Oct 2026
Nonoperative management of colonic fistulas in necrotizing pancreatitis can be effective for low-risk patients, reducing complications and length of stay without affecting survival.
Surg Endosc2 Oct 2026
Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) shows a significantly lower rate of unplanned readmissions compared to percutaneous transhepatic gallbladder drainage (PTGBD) in high-risk acute cholecystitis patients.
Surg Endosc2 Oct 2026
Expert consensus provides critical insights on managing paraconduit herniation (PCH) following esophagectomy, emphasizing prevention and specific patient criteria for repair.
J Gastrointest Surg2 Oct 2026
Laparoscopic and endoscopic cooperative surgery (LECS) is a viable option for managing challenging superficial non-ampullary duodenal tumors, especially those that are larger or more deeply invasive.
BMJ Open2 Oct 2026
Transarterial chemoembolization (TACE) with apatinib significantly enhances survival in patients with unresectable hepatocellular carcinoma (UHCC) compared to TACE alone.